Skin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
J Adv Nurs. 2019 Nov;75(11):2393-2417. doi: 10.1111/jan.14102. Epub 2019 Jul 30.
To: (a) examine which outcome measurement instruments for erythema associated with incontinence-associated dermatitis (IAD) with supporting evidence about measurement properties are available; (b) evaluate the methodological quality of the studies and the quality of the measurement properties; and (c) identify eligible instruments to measure erythema in incontinence-associated dermatitis research.
Systematic review.
MEDLINE, EMBASE, CINAHL and CENTRAL were systematically searched until July 2018 (update December 2018). Additional input was gathered from 151 incontinence-associated dermatitis experts. Cited and citing references of included studies were screened.
The COSMIN Risk of Bias checklist was applied to evaluate the methodological quality of the studies. Reported measurement properties were rated against criteria for good measurement properties.
Fourteen studies, describing 10 measurement instruments, were included. In five instruments, erythema was captured as a separate concept, two studies provided empirical evidence about the measurement properties. The most studied measurement properties were reliability (9 studies), measurement error (4 studies) and criterion validity (4 studies). In one study, internal consistency was examined.
No instrument measuring exclusively erythema associated with incontinence-associated dermatitis exists. There is no single composite incontinence-associated dermatitis measurement instrument that outperforms others. Development or adaption of an instrument to measure erythema associated with incontinence-associated dermatitis is one option to solve this challenge.
The evidence about measurement properties of instruments measuring erythema associated with incontinence-associated dermatitis has not been summarized to date. The lack of an instrument should trigger activities to measure this domain accurately in future clinical trials.
(a) 调查有哪些支持测量属性证据的失禁相关性皮炎（IAD）相关红斑的结局测量工具；(b) 评估研究的方法学质量和测量属性的质量；(c) 确定有资格用于失禁相关性皮炎研究中测量红斑的工具。
系统评价。
系统检索 MEDLINE、EMBASE、CINAHL 和 CENTRAL 直至 2018 年 7 月（2018 年 12 月更新）。还从 151 位失禁相关性皮炎专家那里收集了额外的信息。筛选了纳入研究的参考文献和引用参考文献。
应用 COSMIN 偏倚风险检查表评估研究的方法学质量。根据良好测量属性的标准对报告的测量属性进行评分。
纳入了 14 项研究，描述了 10 种测量工具。在 5 种工具中，红斑被单独捕获为一个概念，有 2 项研究提供了关于测量属性的实证证据。研究最多的测量属性是可靠性（9 项研究）、测量误差（4 项研究）和标准有效性（4 项研究）。在一项研究中，考察了内部一致性。
目前没有专门测量与失禁相关性皮炎相关的红斑的工具。没有一种单一的综合失禁相关性皮炎测量工具优于其他工具。开发或改编一种专门测量与失禁相关性皮炎相关的红斑的工具是解决这一挑战的一种选择。
迄今为止，尚未对测量与失禁相关性皮炎相关的红斑的工具的测量属性进行综合总结。缺乏这样的工具应该促使未来的临床试验中更准确地测量这一领域。
